id	等位基因	注释文本
837	TT	Patients with the rs9923231 TT genotype may require a decreased dose as of acenocoumarol compared to patients with the CC genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence acenocoumarol dose requirements.
836	CT	Patients with the rs9923231 CT genotype may require a decreased dose of acenocoumarol as compared to patients with the CC genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence acenocoumarol dose requirements.
835	CC	Patients with the rs9923231 CC genotype may require an increased dose of acenocoumarol as compared to patients with the TT and CT genotypes. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence acenocoumarol dose requirements.

id	证据的ID	总结
115	1448259376	Genotype CC is associated with increased dose of acenocoumarol in people with Atrial Fibrillation or venous thromboembolism as compared to genotypes CT + TT.
114	1448259324	Allele T is associated with dose of acenocoumarol.
113	1448259259	Allele T is associated with dose of acenocoumarol or phenprocoumon.
112	1448255537	Genotypes CT + TT are associated with decreased dose of acenocoumarol in people with Rheumatic Heart Disease as compared to genotype CC.
111	1184511557	Genotypes CT + TT is associated with decreased dose of acenocoumarol as compared to genotype CC.
110	1183680104	Genotype TT is associated with decreased acenocoumarol dose when treated with acenocoumarol in people with Atrial Fibrillation as compared to genotype CC.
109	827814729	Allele T is associated with decreased dose of acenocoumarol as compared to allele C.
108	982031298	Genotype TT is associated with decreased dose of acenocoumarol as compared to genotype CC.
107	982031288	Genotype CT is associated with decreased dose of acenocoumarol as compared to genotype CC.
106	982015093	Genotype TT is associated with decreased dose of acenocoumarol as compared to genotypes CC + CT.
105	982010039	Genotype CC is associated with increased dose of acenocoumarol as compared to genotype CT.
104	982010028	Genotype TT is not associated with dose of acenocoumarol as compared to genotype CT.
103	982006735	Genotype CT is associated with decreased dose of acenocoumarol as compared to genotype CC.
102	982006724	Genotype TT is associated with decreased dose of acenocoumarol as compared to genotypes CC + CT.
101	981954427	Genotype CC is associated with increased dose of acenocoumarol as compared to genotypes CT + TT.
100	981940056	Genotype CC is associated with increased dose of acenocoumarol as compared to genotypes CT + TT.
99	981859299	Genotype TT is associated with decreased dose of acenocoumarol as compared to genotype CC.
98	981502435	Genotypes CC + CT are associated with increased dose of acenocoumarol or warfarin as compared to genotype TT.
97	1444707179	Genotypes CT + TT are associated with decreased dose of acenocoumarol as compared to genotype CC.
96	1444706967	Genotype TT are associated with decreased dose of acenocoumarol as compared to genotype CC.
95	1444705842	Genotypes CT + TT are associated with decreased dose of acenocoumarol as compared to genotype CC.
94	1444705565	Allele T is associated with decreased dose of acenocoumarol as compared to allele C.
93	1444699595	Allele T is associated with decreased dose of acenocoumarol as compared to allele C.
92	1184754659	Allele T is associated with decreased dose of acenocoumarol as compared to allele C.
91	PA166104938	Annotation of DPWG Guideline for acenocoumarol and VKORC1

id	类型	评论
1255	Update	CA score added as part of scoring system release. LOE assigned following curator review.
1254	Update	Adjusted wording to be same framework as warfarin CA.
1253	Update	Attached DPWG guideline. Removed override. Added conflicting evidence statement.
1252	Update	Reviewed.
1251	Update	Checked - does not need update.
1250	Create	Created

最新招商产品更多>>